sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÓÕ·¢ÐÔ°×ñ°·ç¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > ÓÕ·¢ÐÔ°×ñ°·ç¶¯ÎïÄ£×Ó

ǰÑÔ

°×ñ°·ç(vitiligo)ÊÇÒ»ÖÖ×ÔÉíÃâÒßÐÔ¼²²¡ £¬ÁÙ´²ÒÔ¾ÖÏÞÐÔ»ò·º·¢ÐÔÆ¤·ôð¤Ä¤É«ËØÍÑÊ§ÎªÌØÕ÷¡£±¾²¡ÔÚÈËȺÖеķ¢²¡ÂÊԼΪ0.5£¥ £¬·¢²¡ÎÞÐÔ±ðÓëÖÖ×å²î±ð¡£°×ñ°·çÊÇÓÉÓÚÆ¤·ôºÍëÄҵĺÚËØÏ¸°ûÄÚÀÒ°±ËáøϵͳµÄ¹¦Ð§Ëðʧ¶øÒýÆð £¬Æä¿ÉÄܵķ¢²¡»úÖÆ°üÀ¨×ÔÉíÃâÒß¡¢Éñ¾­ÌåÒºÒòËØ¡¢×ÔÉíϸ°û¶¾ÐÔÒÔ¼°ºÚËØÏ¸°û×Ô»Ùѧ˵¡£ÆäÖÐ×ÔÉíÃâÒßѧ˵ÊÇÏÖÔÚµÄÑо¿ÈÈÃÅ¡£°×ñ°·ç¶¯ÎïÄ£×Ó¿É·ÖΪ×Ô¾õÐÔÄ£×Ó¡¢»¯Ñ§ÍÑÉ«ËØÄ£×ÓÒÔ¼°»ùÒòÐÞÊÎÄ£×Ó¡£

 

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎSL¼¦¡¢Ð¡Êó

¡¾ÔìÄ£»úÖÆ¡¿£º

¹ýÑõ»¯Çâ¾ßÓнÏÇ¿µÄÑõ»¯ÐÔ £¬Í¨¹ý¶àÖÖ;¾¶Ó°Ïìϸ°ûÄÚÐźÅתµ¼¡£ÈôÊÇ±íÆ¤ÄÚ¹ýÑõ»¯Çâ¹ý¶àȺ¼¯ £¬¿ÉÒÔÔì³ÉÑõ»¯Ó¦¼¤×´Ì¬ £¬×ÌÈÅÉúÎïµûßʵÄÑ­»· £¬ÒÖÖÆÏà¹ØÃ¸»îÐÔ £¬Ö±½Ó»ò¼ä½ÓËðÉ˺ÚËØÏ¸°û¡£

Çâõ«¶ÔƤ·ô¾ßÓÐÍÑÉ«Ë÷×÷Óá£Æä×÷ÓûúÖÆ¿ÉÄÜÊǾºÕùÒÖÖÆÀÒ°±Ëáø»îÐÔ £¬Ê¹ÀÒ°±Ë᲻ת»¯Îª¶à°ÍºÍ¶à°Íõ« £¬´Ó¶øÒÖÖÆÐþÉ«ËØºÏ³É¡£Ò²Óп´·¨ÒÔΪ £¬Çâõ«ÍÑɫʵÖÊÉÏÊÇÒ»ÀÒ°±Ëáø½éµ¼µÄϸ°û¶¾×÷Óá£Çâõ«·Ö×ÓÒ×À©É¢½øÈëºÚËØÏ¸°ûµÄÐþÉ«ËØÐ¡Ìå £¬×è¶ÏÐþÉ«ËØÌìÉú £¬Í¬Ê±Çâõ«ÔÚÀÒ°±Ëáø×÷ÓÃϱ»Ñõ»¯ÌìÉúÓж¾ÐԵİëõ«»ùÎïÖÊ £¬µ¼ÖÂϸ°ûéæÃü¡£

Īŵ±½×ÚÊÇÒ»ÖÖÆ¤·ôÍÑÉ«¼Á £¬½Ó´¥Æ¤·ôºóÐγÉõ«°ë¿¹Ô­ £¬ÒÖÖÆÀÒ°±Ëáø»îÐÔ¡¢ïÔÌ­ÐþÉ«ËØÌìÉú £¬´Ó¶øµ¼ÖÂÆ¤·ôÉ«ËØÍÑʧ£»ÄªÅµ±½×Ú»¹¿ÉÒÔʹƤ·ô½Ó´¥ÒÔÍâµÄ²¿Î»±¬·¢É«ËØÍÑʧ¡£

¡¾Ä£×ÓÌØµã¡¿£º

¹ýÑõ»¯ÇâͿĨëàÊóºó £¬ÈâÏ޿ɼûëàÊóÐþɫƤ·ô±ä²Ò°× £¬ËæÓÃҩʱ¼äÑÓÉì £¬·ºÆð°×°ß £¬ÉõÖÁÓÐë·¢É«ËØÍÑʧ¡£Æ¤·ôÇÐÆ¬¾µÏ¿ɼû £¬¼¬²ãºÍëÄÒÄÚÐþÉ«ËØïÔÌ­ £¬ÓеÄëÄÒÄÚÉϲ¿³Ê°×É«¡¢ÖÐÐÄ»ÆÉ«¡¢Ï²¿ÊÇÐþÉ«µÄÉ«ËØ×ª±ä¡£Í¬Ê±µ¥°·Ñõ»¯Ã¸Ôö¸ß £¬µ¨¼î¿áøÏ½µ¡£

ÓÃ30mg/kgÇâõ«Î¹Ê³ºÚè6~8ÖÜºó £¬Ã¨µÄƤë±ä»ÒÉ«¡£½«Çâõ«ÒÔÆ¤ÏÂ×¢Éä»òιʳµÄ·½·¨Ó¦ÓÃÓÚëàÊóºÍBALB/cСÊó £¬¾ùÊӲ쵽ÊÜÊÔ¶¯Îïë·¢µÄÉ«ËØÍÑʧ¡£

½«ÄªÅµ±½×ÚÍâÍ¿ÓÚºÚËØÁöСÊóC57BL/6B16ºó £¬ÓÃÒ©¾Ö²¿ÒÔ¼°Ô¶´¦·Ç½Ó´¥²¿Î»¾ù·º×ª»úËØÍÑʧ°ß £¬ÇÒºÚËØÁöÉú³¤Êܵ½ÒÖÖÆ £¬60£¥Ð¡ÊóÎÞÁöÉúÑÄʱ¼ä£¾100Ìì¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

½ÓÄÉ»¯Ñ§ÍÑÉ«·¨¿ÉÒÔÔÚÓÃÒ©¾Ö²¿»òÔ¶¶ËÓÕ·¢°×ñ°·çÑùÉ«ËØÍÑʧ £¬²¢ÒýÆðµ¥°·Ñõ»¯Ã¸ºÍµ¨¼îõ¥Ã¸Ë®Æ½×ª±ä £¬´ËÀàÄ£×Ó¿ÉÓÃÓÚÆÀ¼ÛÒ©ÎïÁÆÐ§¡£

Īŵ±½×ÚÍâÍ¿ÓÚºÚËØÁöСÊóC57BL/6B16Ä£×Ó £¬Ö÷ÒªÓÃÓÚ°×ñ²·çºÍºÚËØÁöÏ໥¹ØÏµ¼°ºÚËØÁöÖÎÁÆÒªÁìµÄÑо¿¡£ÄªÅµ±½×ÚËäÈ»¿ÉÒÔÒýÆð¿µ½¡¸öÌ屬·¢°×ñ°·ç £¬µ«ÕâÖÖÉ«ËØÍÑʧµÄÎȹÌÐÔÓ볤ÆÚÐÔÉдý½øÒ»²½Ñо¿¡£ÐèҪ˵Ã÷µÄÊÇ £¬ÄªÅµ±½×ÚÔڷǺÚËØÁöСÊóÌåÄÚ²»¿ÉÓÕ·¢°×ñ£·ç±¬·¢¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅÀ¼À¼ £¬ãÆÃ÷£®°×ñ²·ç¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû. ÖлªÒ½Ñ§Êµ¼ùÔÓÖ¾ £¬2008, 7 (3):212-216

2.×£ÒÝÆ½ £¬Ðí°®¶ð. °×ñ°·ç¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®¹ú¼ÊƤ·ôÐÔ²¡Ñ§ÔÓÖ¾ £¬2013,39(2): 120-123

3.¹ÜÊçÓñ£®ÐþÉ«ËØÏà¹ØÑо¿Öж¯ÎïÄ£×ÓµÄÓ¦ÓÃÏ£Íû£®ÖйúʵÑ鶯Îïѧ±¨ £¬2009, 17 (6):475-477

4.Austin L M, Boissy RE, Jacohson BS, et al. The detection of melanocyte auloantibod.ies in the Smyth chicken model for vitiligo. Clin lmmunol Tmmunopathol, 1992, 64 (2): 112-120

5.Gregg RK,Nichols L,Chen Y,et al. Mechanisms of palial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. The journal of immunology,2010, 184(4):1909-1917

6.Harris JE, Harris TH, Weninger W, et al. A mouse model of viti.ligo with focused epidermal depigmentalion requires£®IFN-γ for autoreaclive CD8+T-cell accumulation in the skin. J Invest Dermatol, 2012, 132 (7): 1869-1876

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > ÓÕ·¢ÐÔ°×ñ°·ç¶¯ÎïÄ£×Ó
ÓÕ·¢ÐÔ°×ñ°·ç¶¯ÎïÄ£×Ó

ǰÑÔ

°×ñ°·ç(vitiligo)ÊÇÒ»ÖÖ×ÔÉíÃâÒßÐÔ¼²²¡ £¬ÁÙ´²ÒÔ¾ÖÏÞÐÔ»ò·º·¢ÐÔÆ¤·ôð¤Ä¤É«ËØÍÑÊ§ÎªÌØÕ÷¡£±¾²¡ÔÚÈËȺÖеķ¢²¡ÂÊԼΪ0.5£¥ £¬·¢²¡ÎÞÐÔ±ðÓëÖÖ×å²î±ð¡£°×ñ°·çÊÇÓÉÓÚÆ¤·ôºÍëÄҵĺÚËØÏ¸°ûÄÚÀÒ°±ËáøϵͳµÄ¹¦Ð§Ëðʧ¶øÒýÆð £¬Æä¿ÉÄܵķ¢²¡»úÖÆ°üÀ¨×ÔÉíÃâÒß¡¢Éñ¾­ÌåÒºÒòËØ¡¢×ÔÉíϸ°û¶¾ÐÔÒÔ¼°ºÚËØÏ¸°û×Ô»Ùѧ˵¡£ÆäÖÐ×ÔÉíÃâÒßѧ˵ÊÇÏÖÔÚµÄÑо¿ÈÈÃÅ¡£°×ñ°·ç¶¯ÎïÄ£×Ó¿É·ÖΪ×Ô¾õÐÔÄ£×Ó¡¢»¯Ñ§ÍÑÉ«ËØÄ£×ÓÒÔ¼°»ùÒòÐÞÊÎÄ£×Ó¡£

 

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎSL¼¦¡¢Ð¡Êó

¡¾ÔìÄ£»úÖÆ¡¿£º

¹ýÑõ»¯Çâ¾ßÓнÏÇ¿µÄÑõ»¯ÐÔ £¬Í¨¹ý¶àÖÖ;¾¶Ó°Ïìϸ°ûÄÚÐźÅתµ¼¡£ÈôÊÇ±íÆ¤ÄÚ¹ýÑõ»¯Çâ¹ý¶àȺ¼¯ £¬¿ÉÒÔÔì³ÉÑõ»¯Ó¦¼¤×´Ì¬ £¬×ÌÈÅÉúÎïµûßʵÄÑ­»· £¬ÒÖÖÆÏà¹ØÃ¸»îÐÔ £¬Ö±½Ó»ò¼ä½ÓËðÉ˺ÚËØÏ¸°û¡£

Çâõ«¶ÔƤ·ô¾ßÓÐÍÑÉ«Ë÷×÷Óá£Æä×÷ÓûúÖÆ¿ÉÄÜÊǾºÕùÒÖÖÆÀÒ°±Ëáø»îÐÔ £¬Ê¹ÀÒ°±Ë᲻ת»¯Îª¶à°ÍºÍ¶à°Íõ« £¬´Ó¶øÒÖÖÆÐþÉ«ËØºÏ³É¡£Ò²Óп´·¨ÒÔΪ £¬Çâõ«ÍÑɫʵÖÊÉÏÊÇÒ»ÀÒ°±Ëáø½éµ¼µÄϸ°û¶¾×÷Óá£Çâõ«·Ö×ÓÒ×À©É¢½øÈëºÚËØÏ¸°ûµÄÐþÉ«ËØÐ¡Ìå £¬×è¶ÏÐþÉ«ËØÌìÉú £¬Í¬Ê±Çâõ«ÔÚÀÒ°±Ëáø×÷ÓÃϱ»Ñõ»¯ÌìÉúÓж¾ÐԵİëõ«»ùÎïÖÊ £¬µ¼ÖÂϸ°ûéæÃü¡£

Īŵ±½×ÚÊÇÒ»ÖÖÆ¤·ôÍÑÉ«¼Á £¬½Ó´¥Æ¤·ôºóÐγÉõ«°ë¿¹Ô­ £¬ÒÖÖÆÀÒ°±Ëáø»îÐÔ¡¢ïÔÌ­ÐþÉ«ËØÌìÉú £¬´Ó¶øµ¼ÖÂÆ¤·ôÉ«ËØÍÑʧ£»ÄªÅµ±½×Ú»¹¿ÉÒÔʹƤ·ô½Ó´¥ÒÔÍâµÄ²¿Î»±¬·¢É«ËØÍÑʧ¡£

¡¾Ä£×ÓÌØµã¡¿£º

¹ýÑõ»¯ÇâͿĨëàÊóºó £¬ÈâÏ޿ɼûëàÊóÐþɫƤ·ô±ä²Ò°× £¬ËæÓÃҩʱ¼äÑÓÉì £¬·ºÆð°×°ß £¬ÉõÖÁÓÐë·¢É«ËØÍÑʧ¡£Æ¤·ôÇÐÆ¬¾µÏ¿ɼû £¬¼¬²ãºÍëÄÒÄÚÐþÉ«ËØïÔÌ­ £¬ÓеÄëÄÒÄÚÉϲ¿³Ê°×É«¡¢ÖÐÐÄ»ÆÉ«¡¢Ï²¿ÊÇÐþÉ«µÄÉ«ËØ×ª±ä¡£Í¬Ê±µ¥°·Ñõ»¯Ã¸Ôö¸ß £¬µ¨¼î¿áøÏ½µ¡£

ÓÃ30mg/kgÇâõ«Î¹Ê³ºÚè6~8ÖÜºó £¬Ã¨µÄƤë±ä»ÒÉ«¡£½«Çâõ«ÒÔÆ¤ÏÂ×¢Éä»òιʳµÄ·½·¨Ó¦ÓÃÓÚëàÊóºÍBALB/cСÊó £¬¾ùÊӲ쵽ÊÜÊÔ¶¯Îïë·¢µÄÉ«ËØÍÑʧ¡£

½«ÄªÅµ±½×ÚÍâÍ¿ÓÚºÚËØÁöСÊóC57BL/6B16ºó £¬ÓÃÒ©¾Ö²¿ÒÔ¼°Ô¶´¦·Ç½Ó´¥²¿Î»¾ù·º×ª»úËØÍÑʧ°ß £¬ÇÒºÚËØÁöÉú³¤Êܵ½ÒÖÖÆ £¬60£¥Ð¡ÊóÎÞÁöÉúÑÄʱ¼ä£¾100Ìì¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

½ÓÄÉ»¯Ñ§ÍÑÉ«·¨¿ÉÒÔÔÚÓÃÒ©¾Ö²¿»òÔ¶¶ËÓÕ·¢°×ñ°·çÑùÉ«ËØÍÑʧ £¬²¢ÒýÆðµ¥°·Ñõ»¯Ã¸ºÍµ¨¼îõ¥Ã¸Ë®Æ½×ª±ä £¬´ËÀàÄ£×Ó¿ÉÓÃÓÚÆÀ¼ÛÒ©ÎïÁÆÐ§¡£

Īŵ±½×ÚÍâÍ¿ÓÚºÚËØÁöСÊóC57BL/6B16Ä£×Ó £¬Ö÷ÒªÓÃÓÚ°×ñ²·çºÍºÚËØÁöÏ໥¹ØÏµ¼°ºÚËØÁöÖÎÁÆÒªÁìµÄÑо¿¡£ÄªÅµ±½×ÚËäÈ»¿ÉÒÔÒýÆð¿µ½¡¸öÌ屬·¢°×ñ°·ç £¬µ«ÕâÖÖÉ«ËØÍÑʧµÄÎȹÌÐÔÓ볤ÆÚÐÔÉдý½øÒ»²½Ñо¿¡£ÐèҪ˵Ã÷µÄÊÇ £¬ÄªÅµ±½×ÚÔڷǺÚËØÁöСÊóÌåÄÚ²»¿ÉÓÕ·¢°×ñ£·ç±¬·¢¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕÅÀ¼À¼ £¬ãÆÃ÷£®°×ñ²·ç¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû. ÖлªÒ½Ñ§Êµ¼ùÔÓÖ¾ £¬2008, 7 (3):212-216

2.×£ÒÝÆ½ £¬Ðí°®¶ð. °×ñ°·ç¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®¹ú¼ÊƤ·ôÐÔ²¡Ñ§ÔÓÖ¾ £¬2013,39(2): 120-123

3.¹ÜÊçÓñ£®ÐþÉ«ËØÏà¹ØÑо¿Öж¯ÎïÄ£×ÓµÄÓ¦ÓÃÏ£Íû£®ÖйúʵÑ鶯Îïѧ±¨ £¬2009, 17 (6):475-477

4.Austin L M, Boissy RE, Jacohson BS, et al. The detection of melanocyte auloantibod.ies in the Smyth chicken model for vitiligo. Clin lmmunol Tmmunopathol, 1992, 64 (2): 112-120

5.Gregg RK,Nichols L,Chen Y,et al. Mechanisms of palial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. The journal of immunology,2010, 184(4):1909-1917

6.Harris JE, Harris TH, Weninger W, et al. A mouse model of viti.ligo with focused epidermal depigmentalion requires£®IFN-γ for autoreaclive CD8+T-cell accumulation in the skin. J Invest Dermatol, 2012, 132 (7): 1869-1876

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿